Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![pick1998_2 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::425402956.png) Nick zheng [@pick1998_2](/creator/twitter/pick1998_2) on x 6902 followers
Created: 2025-07-18 15:32:36 UTC

$APLS PUDFA 7/28/25, sNDA of EMPAVELI®(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946231638557618231/c:line.svg)

**Related Topics**
[c3](/topic/c3)
[$apls](/topic/$apls)

[Post Link](https://x.com/pick1998_2/status/1946231638557618231)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

pick1998_2 Avatar Nick zheng @pick1998_2 on x 6902 followers Created: 2025-07-18 15:32:36 UTC

$APLS PUDFA 7/28/25, sNDA of EMPAVELI®(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability.

XXX engagements

Engagements Line Chart

Related Topics c3 $apls

Post Link

post/tweet::1946231638557618231
/post/tweet::1946231638557618231